Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? (Q35099121)

6 August 2017

1 reference

title

Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? (English)

1 reference

6 August 2017

Beril Tom

1

1 reference

6 August 2017

Andreas Dendorfer

series ordinal

2

1 reference

6 August 2017

A H Jan Danser

series ordinal

3

1 reference

6 August 2017

publication date

1 June 2003

1 reference

International Journal of Biochemistry & Cell Biology

6 August 2017

published in

1 reference

6 August 2017

volume

35

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

792-801

1 reference

Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Ramiprilat increases bradykinin outflow from isolated hearts of rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Bradykinin peptides in kidney, blood, and other tissues of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Nephrectomy, converting enzyme inhibition, and angiotensin peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Potentiation of the vascular response to kinins by inhibition of myocardial kininases.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Kinins, the long march--a personal view

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Counterregulatory actions of angiotensin-(1-7).

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Kinin-degrading pathways in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Enhancement of bradykinin and resensitization of its B2 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Bradykinin inhibition of EGF- and PDGF-induced DNA synthesis in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin I-converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Endothelium-derived hyperpolarizing factor(s): updating the unknown

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

A local kallikrein-kinin system is present in rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Kinin receptors in human vascular tissue: their role in atheromatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-(1-7) is a modulator of the human renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Vasoconstriction is determined by interstitial rather than circulating angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Stimulation of bradykinin B(1) receptors induces vasodilation in conductance and resistance coronary vessels in conscious dogs: comparison with B(2) receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Bradykinin metabolism in the isolated perfused rabbit heart

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Bradykinin potentiation by ACE inhibitors: a matter of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Negative inotropic effect of bradykinin in porcine isolated atrial trabeculae: role of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

Converting enzyme determines plasma clearance of angiotensin-(1-7)

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900273-X

7 January 2021

10.1016/S1357-2725(02)00273-X

Identifiers

DOI

1 reference

6 August 2017

1 reference